In gene prediction, the Fisher discriminant analysis (FDA) is used to separate protein coding region (exon) from noncoding regions (intron). Usually, the positive data set and the negative data set are of the same size if the number of the data is big enough. But for some situations the data are not sufficient or not equal, the threshold used in FDA may have important influence on prediction results. This paper presents a study on the selection of the threshold. The eigen value of each exon/intron sequence is computed using the Z-curve method with 69 variables. The experiments results suggest that the size and the standard deviation of the data sets and the threshold are the three key elements to be taken into consideration to improve the prediction results.
Introduction
Protein coding region and non-coding region of a DNA sequence are also called exon and intron respectively. Gene prediction of eukaryotes is still one of the most important research domains of bioinformatics for the prediction accuracy is needed to be improved [1] . Fisher Discriminant analysis/algorithm (FDA) is widely used in solving binary classification problems like fault classification [2] , gene expression data classification [3] , image categorization [4] , integrating heterogeneous data sets [5] and DNA sequence classification [6, 7] , and it has attracted more and more attention. Kernel FDA (KFDA) may present out performance in both simulation time consume and classification precision than support vector machine (SVM) for it does not need to solve any quadratic problem [8, 9] . For maximizing the uniformity of classpair separabilities and class separability in kernel space simultaneously, a novel kernel FDA kernel parameters optimization criterion is presented [10] . A novel dimensionality reduction algorithm based on FDA is proposed for ranking applications such as visual search re-ranking [11] .
Usually, the size of the training and test data sets are selected equal and the threshold is determined by making the false negative rate and the false positive rate equal [6] ; but for some real situations, the threshold could not be obtained by the method because the sizes of the positive and negative data sets are unbalanced. In the latter situation, there are five possible thresholds for making the coding/non-coding decision. Using the exon and intron data sets downloaded from the website: http://www.fruitfly.org/seq_tools/datasets/Human/, the FDA based experiments show that the size and the standard deviation of the data sets are the two key elements to be taken into consideration to improve the prediction results.
Data Sets and Methods

The Data Sets
The Data sets used in this paper were downloaded from the above net address. The Data were separated into 7 parts in the website, and each part consists of an exon sub-set and an intron sub-set. There are 301 DNA fragments at least and 448 at most in each sub-set as detailed in Table 1 .
The difference values between the numbers of exons and introns in each part are all 66 from the Table 1 . Exon  367  448  447  389  399  402  391  Intron  301  382  381  323  333  336  325  Total  668  830  828  712  732  738  716 
The Z Curve Methods
The Z curve method is a powerful tool to visualize and analyze DNA sequences. It is also one of the most widely used mapping methods which maps a DNA sequence into three digital sequences. According to [6] , the prediction results of the Z curve method with 69 variables are almost the same with that of 169 variables ones. So, the Z curve method with 69 variables is applied in this paper. The 69 variables are composed with 9 Z curve parameters for frequencies of phase-specific mononucleotides, 12 Z curve parameters for frequencies of phase independent di-nucleotides and 48 Z curve parameters for frequencies of phase independent tri-nucleotides. These Z curve parameters are defined below. Let A, T, C and G represent base adenine, thymine, cytosine and guanine respectively. The bases A, T, C, G are occurring in a DNA fragment at positions 1, 4, 7, …; 2, 5, 8, …; and 3, 6, 9, …, with
c , 3 g respectively. Then by using the Z-transform defined by Equation (1), a fragment of DNA sequence is transformed into the 9 Z curve parameters for frequencies of phase-specific mononucleotides. 
Let ( ) p XY be the frequency of the di-nucleotides XY ( , C G T X Y A = , , , ), the 12 variables for frequencies of phase independent di-nucleotides are given by
The last 48 Z curve parameters for frequencies of phase independent tri-nucleotides can be obtained using the similar notations by
Next, the 69 variables of each exon/intron are 9  9  9  12  12  12  48  48  48  1  2  9  1  2  12  1  2  48 , , , , , , , , , , , u u u u u u u u u    . They are defined by Equations (4) to (8) . These 9  9  9  1  1  2  2  3  3   9  9  9  4  1  5  2  6  3   9  9  9  7  1  8  2  9  3 , , , 12  12  12  12  1  2  3  4  12  12  12  12  5  6  7  8  12  12  12  12  9  10  11  12 , , , 48  48  48  48  1  2  3  4  48  48  48  48  5  6  7  8  48  48  48  48  9  10  11  12  48  48  48  48  13  14  15  16 , , , . (7) 48 48  48  48  33  34  35  36  48  48  48  48  37  38  39  40  48  48  48  48  41  42  43  44  48  48  48  48  45  46  47  48   ,  ,  , 
The Fisher Discriminant Analysis/Algorithm
be the data matrix, where N and M are the number of data/samples and the dimension of each data respectively. The M is also the number of the best FDA coefficients, which are 1 2 , , , M u u u  . In this paper the dimension of the data is 69, that is 69 M = . Each exon/Intron is described by a point or row vector x in a 69-dimensional (69-D) space spanned by 9  9  9  12  12  12  48  48  48  1  2  9  1  2  12  1  2  48   1  2  69 ( , , , , , , , , , , , )
There are two groups of samples in the training data set used in FDA. One contains positive samples which belong to sample space p w , and another contains the negative samples which belong to sample space n w . The positive samples are DNA fragments from real exons and the negative samples are from the real introns. 
The best FDA coefficients consists a column vector u . Using the divergence matrix W S , the vector u is defined as the best projecting direction (BPD) and is given by ( ) ( ) ( )
, , , ,
where "T" indicates the transpose of a matrix, and the divergence matrix W S is defined as
Once the u and the threshold c are obtained, the discrimination of exon/intron for each DNA fragment in the test set is carried out by 0 0 ( )
The Threshold
( ) 
For situation where p n N N = , the threshold is uniquely determined by letting the false negative rate (FNR) be equal to the false positive rate (FPR) [6, 7] . The details will be given in the next section of this paper.
The Z Curve Mark of the DNA Sequence
The best projecting direction u can be interpreted as the weight vector corresponds to the 69 Z curve values of each test sample. The Z curve score (ZCS) of each DNA sequence is defined as ZCM = × u x, where the "×" is the multiplication cross symbol, " u "and " x " are the best project direction and row vector of a DNA sequence. The ZCS is too small to be display directly, so a transform named remainder and multiple (RM) is carried out. The RM transform is defined as
where "MOD" and "floor" are two MATLAB function names. Function "mod(x, y)" returns the modulus of "x" after it is devided by "y", and function "floor(x)" rounds the elements of "x" to the nearest integers. In this work, the "M" in the RM transform is set to 3. Thus, the ZCS of a DNA sequence can be displayed in a two dimensional surface with the rounds ( ( ) M ZCS ) and the modulus ( ( ) R ZCS ) are the two coordinate axis.
Results and Discussion
The Prediction Accuracy Measures
To measure the prediction accuracy, the sensitivity and the specificity are applied. They are defined by Equations (19) and (20) respectively.
where TP TN is the number of true exons/introns which were predicted as exons/introns, and the FP/FN is the number of true introns/exons which were predicted as exons/introns [12] . The prediction average accuracy is defined as ( ) 
The Statistics of the ZCS of Data Sets. To clear the relationship between the data sets and the prediction results, the statistics nature of the 7 data parts are presented in Tables 2 and 3. These statistics nature include mean and standard deviation of the Z curve value. Figure 1 gives the ZCS scatter diagram of the Part0 to Part6 with the RM transform is applied to the ZCS of each sequence. 
Test with Different Training/Testing Sets
To study the relationship between size of the training samples and the prediction results, two experiments were carried out. In the first experiment, let part0 be the training data set (TRDS) and the rest 6 parts together (NPart0) be the test data set (TEDS) at first. Then let part1 be the training set and the rest 6 parts together (NPart1) be the test set, and so on. Table 4 gives the prediction results. From the mean prediction accuracies listed in the Table 5, the third and the fifth thresholds present a little better prediction than the three others.
In the second experiment, let the part0 be the training set (1Parts) at first, and then let the part0 and the part1 (2Parts)be the training set, and so on. In this experiment, the testing set includes all the seven parts. Table 6 gives the prediction result using the c 5 as the threshold. Figure  2 shows the BPD obtained with training sets as mentioned like 1Parts, 2Parts, etc. The BPDs changed greatly as the size of training data set increased, which is confirmed by the prediction accuracy listed in Table 6 . The mean and standard deviation of the Z curve value in Tables 2 and 3 also show the same correlation. Table 6 . Prediction result with increased training set.
TRDS Part0
Part0-Part1
Part0-Part2
Part0-Part3
Part0-Part4
Part0-Part5 
Concluding Remarks
In this work, some studies on the relationships between the prediction accuracy and some parameters alike have been carried out. The experiments based on FDA show that the mean, the standard deviation of the testing/training data sets and the threshold are the three key elements to improve the classification accuracy.
